Oral Answers to Questions

Debate between Robin Walker and Daniel Zeichner

Thursday 16th May 2019 Commons Chamber

[Daniel Zeichner (Cambridge) (Lab)]

6. What recent discussions he has had with the Home Secretary on the effectiveness of the EU settlement scheme for European economic area nationals.

[The Parliamentary Under-Secretary of State for Exiting the European Union (Mr Robin Walker)]

This is a hugely important scheme designed to help EEA and EU citizens take up their rights and deliver on the Government’s commitment that we want them to stay. I regularly meet colleagues in the Home Office to discuss the scheme, and it is important to note that the Home Office has received more than 650,000 applications so far, with thousands more being received every week. Applications are free and there is plenty of time to apply.

[Daniel Zeichner]

If the Government really wanted to make non-UK EU nationals feel welcome and wanted them to stay, they would make this an easy system. In fact, people have to have the right phone. If they do not have the right phone, they have to go to an ID scanning centre. But just look at where those centres have been placed; they are all around London, so the Secretary of State’s constituents and my constituents have to travel all the way to Bedford, Peterborough or London. Why is there not at least an ID scanning centre in every county?

[Mr Walker]

The hon. Gentleman makes an important point about the accessibility of the scheme, and I agree that it should be accessible. There are going to be 200 assisted digital locations across the UK to support people to register, including one in the hon. Gentleman’s constituency of Cambridge, which he should welcome.

Oral Answers to Questions

Debate between Robin Walker and Daniel Zeichner

Thursday 14th December 2017 Commons Chamber

[Daniel Zeichner (Cambridge) (Lab)]

13. What progress the Government have made on negotiating with the EU continuing co-operation on the regulation of medicines after the UK leaves the EU.

[The Parliamentary Under-Secretary of State for Exiting the European Union (Mr Robin Walker)]

We worked intensively with our European partners to settle the issues in the first phase of negotiations, and as the hon. Gentleman knows, we published a joint report. We now want to focus our efforts on quickly agreeing the detail of a time-limited implementation period to give certainty to people and businesses. As the Secretaries of State for Business and for Health emphasised in their open letter to the Financial Times earlier this year, as we enter the next phase we want to work closely with the European Medicines Agency and international partners in the interests of public health.

[Daniel Zeichner]

The high costs of not maintaining regulatory alignment for medicines were recently laid bare in evidence to the BEIS Select Committee. If alignment is not achieved, how much would prescription charges have to go up? Is regulatory alignment the Government’s objective? If so, what is the point in all this?

[Mr Walker]

As part of our exit negotiations, we have been clear that we want to discuss with the EU and member states how best to continue co-operation in the field of medicines regulation in the best interests of businesses, citizens and patients in the UK and the EU. Of course, what we cannot do is prejudge the outcome of those negotiations.